Haemonetics Corp - ESG Rating & Company Profile powered by AI
Complete Sustainability assessment of Haemonetics Corp are accessed by registering for free. This webpage is a free E,S&G analysis for Haemonetics Corp. The assessment of Haemonetics Corp incorporates data points from across the web as well as from public filings by Haemonetics Corp.
Haemonetics Corp in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 2.3; made up of an environmental score of 2.3, social score of 1.1 and governance score of 3.4.
2.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Becton Dickinson and Co | 8.6 | High |
| 2 | DENTSPLY SIRONA Inc | 8.4 | High |
| ... | ... | ... | |
| 366 | Wiltrom Co Ltd | 2.4 | Medium |
| 366 | iRay Technology Co Ltd | 2.4 | Medium |
| 372 | Haemonetics Corp | 2.3 | Medium |
| 372 | Autobio Diagnostics Co Ltd | 2.3 | Medium |
| 372 | Bluelinea SA | 2.3 | Medium |
| ... | ... | ... | |
| 526 | Valeritas Holdings Inc | 0.0 | Low |
| 526 | ZoomMed Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Haemonetics Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Haemonetics Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Haemonetics Corp report the average age of the workforce?
Sign up for free to unlockDoes Haemonetics Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Haemonetics Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Haemonetics Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Haemonetics Corp offer flexible work?
Sign up for free to unlockDoes Haemonetics Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Haemonetics Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Haemonetics Corp conduct supply chain audits?
Sign up for free to unlockDoes Haemonetics Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Haemonetics Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Haemonetics Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Haemonetics Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Haemonetics Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Haemonetics Corp disclose water use targets?
Sign up for free to unlockDoes Haemonetics Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Haemonetics Corp have a product recall in the last two years?
Sign up for free to unlockDoes Haemonetics Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Haemonetics Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Haemonetics Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Haemonetics Corp disclose parental leave metrics?
Sign up for free to unlockDoes Haemonetics Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Haemonetics Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Haemonetics Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Haemonetics Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Haemonetics Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Haemonetics Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Haemonetics Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Haemonetics Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Haemonetics Corp disclose its waste policy?
Sign up for free to unlockDoes Haemonetics Corp report according to TCFD requirements?
Sign up for free to unlockDoes Haemonetics Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Haemonetics Corp disclose energy use targets?
Sign up for free to unlockDoes Haemonetics Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Haemonetics Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Haemonetics Corp
These potential risks are based on the size, segment and geographies of the company.
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.